Special Projects of National Significance Curing Hepatitis C (HCV) Among People of Color Living With HIV Initiative: Improving Linkage to and Retention in HCV,Behavioral Health and Substance Use Disorder (SUD) Care

Aggarwal R. Chen Q. Goel A. Seguy N. Pendse R. Ayer T. Chhatwal J. (2017). Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India. PLOS ONE, 12(5), e0176503. https://doi.org/10.1371/journal.pone.0176503

Allegrante J. P. Wells M. T. Peterson J. C. (2019). Interventions to support behavioral self-management of chronic diseases. Annual Review of Public Health, 40, 127–146. https://doi.org/10.1146/annurev-publhealth-040218-044008

Alshuwaykh O. Kwo P. Y. (2020). HCV treatment in 2020: How to translate highly effective therapies into elimination strategies. Hepatology Forum, 1(2), 72–74. https://doi.org/10.14744/hf.2020.2020.0009

Backus L. I. Belperio P. S. Shahoumian T. A. Mole L. A. (2019). Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease. Hepatology, 69(2), 487–497. https://doi.org/10.1002/hep.29408

Benhamou Y. Bochet M. Martino V. D. Charlotte F. Azria F. Coutellier A. Vidaud M. Bricaire F. Opolon P. Katlama C. Poynard T. (1999). Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients—The multivirc group. Hepatology, 30(4), 1054–1058. https://doi.org/10.1002/hep.510300409

Bosh K. A. Coyle J. R. Hansen V. Kim E. M. Speers S. Comer M. Maddox L. M. Khuwaja S. Zhou W. Jatta A. Mayer R. Brantley A. D. Muriithi N. W. Bhattacharjee R. Flynn C. Bouton L. John B. Keusch J. Barber C. A. . . .Hall H. I. (2018). HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities. Epidemiology & Infection, 146(7), 920–930. https://doi.org/10.1017/S0950268818000766

Bosh K. A. Johnson A. S. Hernandez A. L. Prejean J. Taylor J. Wingard R. Valleroy L. A. Hall H. I. (2020). Vital signs: Deaths among persons with diagnosed HIV infection, United States, 2010-2018. Morbidity and Mortality Weekly Report (MMWR), 69(46), 1717–1724. https://doi.org/10.15585/mmwr.mm6946a1

Centers for Disease Control and Prevention. (2020). HIV surveillance report (Vol. 33). https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html

Choo Q. L. Kuo G. Weiner A. J. Overby L. R. Bradley D. W. Houghton M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244(4902), 359–362. https://doi.org/10.1126/science.2523562

Du P. Yin X. Kong L. Jung J. (2021). A telementoring program and hepatitis C virus care in rural patients. Telemedicine Reports, 2(1), 143–147. https://doi.org/10.1089/tmr.2021.0001

Eisinger R. W. Dieffenbach C. W. Fauci A. S. (2019). HIV viral load and transmissibility of HIV infection: Undetectable equals untransmittable. Journal of the American Medical Association, 321(5), 451–452. https://doi.org/10.1001/jama.2018.21167

El-Sadr W. M. Mayer K. H. Rabkin M. Hodder S. L. (2019). AIDS in America—Back in the headlines at long last. The New England Journal of Medicine, 380(21), 1985–1987. https://doi.org/10.1056/NEJMp1904113

Fialho R. Pereira M. Rusted J. Whale R. (2017). Depression in HIV and HCV co-infected patients: A systematic review and meta-analysis. Psychology, Health & Medicine, 22(9), 1089–1104. https://doi.org/10.1080/13548506.2017.1280177

Ginossar T. Oetzel J. Van Meter L. Gans A. A. Gallant J. E. (2019). The Ryan White HIV/AIDS Program after the Patient Protection and Affordable Care Act full implementation: A critical review of predictions, evidence, and future directions. Topics in Antiviral Medicine, 27(3), 91–100.

Health Resources and Services Administration. (2022, September). RWHAP—Part F: Special projects of national significance—Program fact sheet. https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/about-program/program-factsheet-part-f-spns.pdf

Mendenhall E. Singer M. (2020). What constitutes a syndemic? Methods, contexts, and framing from 2019. Current Opinion in HIV and AIDS, 15(4), 213–217. https://journals.lww.com/co-hivandaids/Fulltext/2020/07000/What_constitutes_a_syndemic__Methods,_contexts,.2.aspx

Quinn K. G. John S. A. Hirshfield S. Algiers O. O’Neil A. Petroll A. E. Walsh J. L. (2022). Challenges to meeting the HIV care needs of older adults in the rural South. SSM—Qualitative Research in Health, 2, Article 100113. https://doi.org/10.1016/j.ssmqr.2022.100113

Ramani A. Tapper E. B. Griffin C. Shankar N. Parikh N. D. Asrani S. K. (2022). Hepatocellular carcinoma-related mortality in the USA, 1999-2018. Digestive Diseases and Sciences, 67(8), 4100–4111. https://doi.org/10.1007/s10620-022-07433-8

Roe B. Hall W. W. (2008). Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus. Expert Reviews in Molecular Medicine, 10, Article e30. https://doi.org/10.1017/S1462399408000847

Siegler A. J. Mouhanna F. Giler R. M. Weiss K. Pembleton E. Guest J. Jones J. Castel A. Yeung H. Kramer M. McCallister S. Sullivan P. S. (2018). The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Annals of Epidemiology, 28(12), 841–849. https://doi.org/10.1016/j.annepidem.2018.06.005

Smith C. M. Kennedy J. L. Evans M. E. Person M. K. Haverkate R. Apostolou A. (2022). Mental illness in adults with HIV and HCV infection: Indian health service, 2001-2020. American Journal of Preventive Medicine, 63(3), e77–e86. https://doi.org/10.1016/j.amepre.2022.03.023

Sullivan P. S. Satcher Johnson A. Pembleton E. S. Stephenson R. Justice A. C. Althoff K. N. Bradley H. Castel A. D. Oster A. M. Rosenberg E. S. Mayer K. H. Beyrer C. (2021). Epidemiology of HIV in the USA: Epidemic burden, inequities, contexts, and responses. The Lancet, 397(10279), 1095–1106. https://doi.org/10.1016/s0140-6736(21)00395-0